Honasa Consumer Limited HONASA

Honasa Consumer Ltd (NSE:HONASA) delivers strong Q1 FY27 with 30.5% volume growth, EBITDA margin expansion, and successful scaling of The Derma Co. to INR1,000 crore brand.

Honasa Consumer Ltd reports a robust 28% YoY growth in Q4 FY26, with strategic focus on brand expansion and premiumization driving future prospects.

Honasa Consumer’s fair value has been held around ₹374.85 per share, with no material change to the prior price target. Analysts are treating this steady target near ₹375 as a reference point to weigh any potential upside against the execution risks already built into their models. As you read on, you will see how to track these assumptions and what to watch as the narrative around Honasa Consumer evolves. Analyst Price Targets don't always capture the full story. Head over to our Company...

Honasa Consumer is back in focus after analysts lifted their modelled fair value estimate from ₹328.77 to ₹374.85, a change of around 14% in the price target. Supportive commentary links this move to refreshed assumptions around earnings quality, while more cautious voices question how much of that optimism may already be priced in. As you read on, you will see how to track this evolving narrative and what it could mean for your own view on the stock. Analyst Price Targets don't always...

Honasa Consumer Ltd (NSE:HONASA) achieves its highest ever quarterly revenue and EBITDA, while navigating competitive pressures and cost management challenges.